Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Center for Emergency Medicine Research, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Shock. 2019 Aug;52(2):166-173. doi: 10.1097/SHK.0000000000001258.
The complex host response to sepsis is incompletely understood. The aim of this investigation is to use leukocyte RNA sequencing to characterize biological functions, cellular pathways, and key regulatory molecules driving sepsis pathophysiology.
This was a prospective, observational study of emergency department patients with sepsis, at an urban, academic, tertiary care center. In the derivation cohort, we collected blood at enrollment and 90 days after hospital discharge allowing each patient to serve as an internal control. We performed RNA sequencing to quantify transcriptional expression changes during sepsis and non-sepsis states. We then performed unsupervised and supervised analyses, as well as functional and pathway analyses. We selected the top down and upregulated genes and key regulatory molecules for validation. Validation occurred in a cohort of septic and non-septic using real-time PCR.
The derivation cohort included 5 patients, and RNA sequencing revealed 916 unique mRNA transcripts differentially expressed during sepsis. Among these, 673 (73%) genes were upregulated, and 243 (27%) were downregulated. Functional enrichment analysis revealed a highly dynamic downstream effect of the transcriptional activity during sepsis. Of the 43 functional cellular pathways activated during sepsis, the top pathways were closely associated with inflammation and response to infection. Validation occurred in 18 septic and 25 non-septic control patients, with 34/45 (76%) of identified genes validated. The regulatory analysis identified several key regulators of sepsis.
Highly dynamic transcriptional activity occurs in leukocytes during sepsis, activating key cellular pathways and master regulatory molecules that drive the sepsis process.
人们对脓毒症的复杂宿主反应仍了解不充分。本研究旨在使用白细胞 RNA 测序来描述生物学功能、细胞通路和驱动脓毒症发病机制的关键调控分子。
这是一项在城市学术三级护理中心进行的前瞻性、观察性研究,纳入急诊科脓毒症患者。在推导队列中,我们在入组时和住院后 90 天采集血液,使每位患者都可作为自身对照。我们进行 RNA 测序以量化脓毒症和非脓毒症状态下的转录表达变化。然后我们进行了无监督和有监督分析以及功能和通路分析。我们选择上调和下调最明显的基因和关键调控分子进行验证。在使用实时 PCR 的脓毒症和非脓毒症患者队列中进行验证。
推导队列纳入了 5 例患者,RNA 测序显示脓毒症期间有 916 个独特的 mRNA 转录物差异表达。其中,673 个(73%)基因上调,243 个(27%)基因下调。功能富集分析显示脓毒症期间转录活性的下游效应具有高度动态性。在脓毒症期间激活的 43 个功能细胞通路中,前 5 个通路与炎症和感染反应密切相关。在 18 例脓毒症和 25 例非脓毒症对照患者中进行了验证,其中 34/45(76%)鉴定的基因得到验证。调控分析确定了一些脓毒症的关键调控分子。
脓毒症期间白细胞中发生高度动态的转录活性,激活关键细胞通路和驱动脓毒症进程的主要调控分子。